Loading...
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer
Rigon, Manuel Mutti, Luciano Campanella, Michelangelo
Rigon, Manuel
Mutti, Luciano
Campanella, Michelangelo
Citations
Altmetric:
Genre
Journal article
Date
2024-03-08
Advisor
Committee member
Department
Biology
Subject
Permanent link to this record
Collections
Files
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1002/1878-0261.13591
Abstract
Mesothelioma is a type of late-onset cancer that develops in cells covering the outer surface of organs. Although it can affect the peritoneum, heart, or testicles, it mainly targets the lining of the lungs, making pleural mesothelioma (PMe) the most common and widely studied mesothelioma type. PMe is caused by exposure to fibres of asbestos, which when inhaled leads to inflammation and scarring of the pleura. Despite the ban on asbestos by most Western countries, the incidence of PMe is on the rise, also facilitated by a lack of specific symptomatology and diagnostic methods. Therapeutic options are also limited to mainly palliative care, making this disease untreatable. Here we present an overview of biological aspects underlying PMe by listing genetic and molecular mechanisms behind its onset, aggressive nature, and fast-paced progression. To this end, we report on the role of deubiquitinase BRCA1-associated protein-1 (BAP1), a tumour suppressor gene with a widely acknowledged role in the corrupted signalling and metabolism of PMe. This review aims to enhance our understanding of this devastating malignancy and propel efforts for its investigation.
Description
Citation
Rigon, M., Mutti, L. and Campanella, M. (2024), Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer. Mol Oncol, 18: 797-814. https://doi.org/10.1002/1878-0261.13591
Citation to related work
Wiley
Has part
Molecular Oncology, Vol. 18, Iss. 4
ADA compliance
Embedded videos
License
Attribution CC BY